SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$1.17
-0.01 (-0.85%)
Open$1.17
Previous Close$1.18
Day High$1.17
Day Low$1.12
52W High$6.92
52W Low$0.85
Volume—
Avg Volume700.1K
Market Cap2.09M
P/E Ratio—
EPS$-2.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,005.1% upside
Current
$1.17
$1.17
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.56M | 19.73M | 1.82M |
| Net Income | -4,975,469 | -4,297,430 | 463.1K |
| Profit Margin | -24.2% | -23.0% | 25.4% |
| EBITDA | -4,334,983 | -3,952,239 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +4.2% | +4.2% | -7.1% |
| Debt/Equity | 0.05 | 0.05 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |